Microarray analysis has found that FADS2 expression is significantly upregulated compared to that in normal tissues, especially paracancerous tissues, melanoma tissues, lung cancer tissues and brain cancers (Sun et al., 2006; He et al., 2012; Jiang et al., 2017). This evidence concerns the gene FADS2 and brain cancer.